Ameritas Investment Company’s Halozyme HALO Stock Holding History

Ameritas Investment Company’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-38	Closed	-$1K	–	1337
2018 Q4	$1K	Buy	+38	New	+$606	﹤0.01%	1429

Other funds holding HALO

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PAMU

Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Ameritas Investment Company's HALO Position: Q1 2019 in Review

Ameritas Investment Company sold out of Halozyme (HALO) in Q1 2019, closing a stake of 38 shares — an estimated $1K sold.

Ameritas Investment Company first reported a position in HALO in Q4 2018 and held it in 1 quarter. The position peaked at $1K in Q4 2018. 201 funds tracked by Wall St. Rank hold HALO as of Q1 2019.

Ameritas Investment Company reported no remaining Halozyme position as of Q1 2019 after selling out during the quarter.
Ameritas Investment Company sold 38 Halozyme shares in Q1 2019, an estimated $1K.
Ameritas Investment Company first reported a position in Halozyme in Q4 2018 and held it in 1 quarter.
Ameritas Investment Company's Halozyme position peaked at $1K in Q4 2018.
201 funds tracked by Wall St. Rank held Halozyme as of Q1 2019.

Based on Ameritas Investment Company's 13F filing for Q1 2019, filed 16 May 2019.